Does Q32 Bio (QTTB) Have the Potential to Rally 97.66% as Wall Street Analysts Expect?

Consensus analyst price target implies a 97.7% upside for Q32 Bio (QTTB). Empirical research cautions that price targets are often unreliable, reducing conviction in that headline upside. However, an upward trend in earnings estimate revisions provides a constructive near-term signal that could support stock appreciation for the individual ticker.

Analysis

Consensus analyst price target implies a 97.7% upside for Q32 Bio (QTTB). Empirical research cautions that price targets are often unreliable, reducing conviction in that headline upside. However, an upward trend in earnings estimate revisions provides a constructive near-term signal that could support stock appreciation for the individual ticker.